genetic vaccine also genebased vaccine vaccine contains nucleic acids dna rna lead protein biosynthesis antigens within cell genetic vaccines thus include dna vaccines rna vaccines viral vector vaccines vaccines live attenuated vaccines genetic vaccines taken mhcipresenting cells act outside cells producing strong humoral immune response via antibodies case intracellular pathogens exclusive humoral immune response genetic vaccines based principle uptake nucleic acid cells whereupon protein produced according nucleic acid template protein usually immunodominant antigen pathogen surface protein enables formation neutralizing antibodies inhibit infection cells subsequently protein broken proteasome short fragments peptides imported endoplasmic reticulum via transporter associated antigen processing allowing bind mhcimolecules subsequently secreted cell surface presentation peptides mhci complexes cell surface necessary cellular immune response result genetic vaccines live vaccines generate cytotoxic tcells addition antibodies vaccinated individual contrast live vaccines parts pathogen used means reversion infectious pathogen occur happened polio vaccinations sabin genetic vaccines commonly administered injection intramuscular subcutaneous infusion less commonly dna gene gun electroporation viral vectors mechanisms taken cells dna rna must introduced cells via method transfection humans cationic lipids used conjunction electrically neutral helper lipids allows nucleic acid taken endocytosis released cytosol examples genetic vaccines approved use humans include rna vaccines tozinameran dna vaccine zycovd well viral vectors sputnik v addition genetic vaccines investigated proteins various infectious agents proteinbased cancer tolerogenic vaccines hyposensitization type first use viral vector vaccination modified vaccinia ankara virus expressing hbsag published bernard moss dna used vaccine jeffrey ulmer colleagues first use rna vaccination purposes described frédéric martinon pierre meulien x zhou peter liljeström colleagues martinon demonstrated cellular immune response induced vaccination rna robert conry colleagues described humoral immune response also elicited vaccination rna dna vaccines frequently researched early years due ease production low cost high stability degrading enzymes sometimes produced low vaccine responses despite containing immunostimulatory cpg research later conducted rna vaccines whose immunogenicity often better due inherent adjuvants unlike dna insert genome vaccinated accordingly first rna dnabased vaccines approved humans rna dna vaccines used covid vaccines viral vectors previously approved ebola vaccines httpsenwikipediaorgwikigeneticvaccine